Philip Morris International: Scaling Smoke-Free Portfolios Amidst 28.3% Net Margins

PM

Leveraging 7.2% top-line growth to fund the transition toward high-yield reduced-risk product categories

Comprehensive Financial Analysis • 2026-04-09

1

Company Profile & Classification

Sector, moat, style, market positioning

2

Equity Performance & Market Positioning

Returns, risk metrics, smart money positioning

3-4

3

Revenue, Earnings & Margin History

Growth trajectory, margins, EPS, cost structure

5-6

4

Profitability & Return on Capital

DuPont, ROIC, efficiency, asset turnover

7-9

5

Balance Sheet & Cash Flow Health

Liquidity, solvency, cash flow, FCF statistics

10-12

6

Executive Insights & Key Takeaways

Summary and investment implications

13

Company Profile & Classification

PM — Philip Morris International Inc.

Consumer Defensive · Tobacco $254.58B · Mega Cap B2C/B2B Mixed

Business & Competitive Position

💰 Revenue Model Product/Service Sales

🏗️ Asset Profile Mixed Asset Base

🛡️ Economic Moat

Wide Moat (Scale + Margins)

🔒 Scale🔒 Brand🔒 Cost Advantages

📈 Pricing Power

Strong

🏆 Market Position Market Leader

Growth & Valuation

🎯 Invest Style

Value Blend Growth Quality

🚀 Growth

Declining Low Moderate High

📊 Revenue +7.2% YoY

🔄 Cyclicality

Defensive Mod Cyclical Highly Cyclical

💲 Valuation

21.0x P/E 16.7x EV/EBITDA 3.57% Div

⚖️ Tier

Fair Value

📊 Beta 0.40 (Low Volatility)

Philip Morris International (PM) is a global tobacco leader currently executing a high-stakes pivot from traditional combustibles to a reduced-risk, smoke-free product portfolio anchored by IQOS and ZYN. With a $254.58B market cap and a wide moat derived from unmatched brand equity and global distribution, the company maintains a dominant position in international markets while aggressively expanding its nicotine pouch footprint in the United States. Financially, PM is characterized by elite profitability, sporting a 37.5% operating margin and a 28.3% net margin that allow it to fund its business transformation while returning significant capital to shareholders. As a defensive powerhouse with a low 0.40 beta, it offers investors a unique combination of high-margin stability and a structural growth narrative centered on the industry's technological evolution.

The 7.2% YoY revenue growth to $40.6B reflects a successful category mix shift, as higher-value smoke-free products now contribute over 36% of total net revenues, providing a growth tailwind that compensates for secular declines in cigarette volumes.
PM's robust 37.5% operating margin is sustained by exceptional pricing power and cost advantages, which allow the company to absorb inflationary pressures and heavy R&D investments without compromising its industry-leading profitability profile.
A defensive beta of 0.40 highlights the stock's role as a volatility hedge, offering capital preservation and reliable dividend income for investors seeking shelter from cyclical economic downturns and broader market instability.
The current 21.0x P/E ratio represents a fair valuation for a mega-cap leader that has successfully de-risked its business model through the acquisition of Swedish Match, effectively capturing the high-growth U.S. oral nicotine market to diversify its geographic revenue base.

Equity Performance & Market Positioning

Philip Morris International Inc. (PM) — Stock Returns

Recent Performance

-7.1%

1 Month

vs S&P -6.9

3.7%

3 Month

vs S&P +6.1

4.8%

6 Month

vs S&P +4.2

0.3%

YTD

vs S&P +1.3

8.7%

1 Year

vs S&P -25.0

PM's 1-year return of 8.7% significantly outperformed the S&P 500's 25.0% decline, demonstrating the stock's role as a defensive 'safe haven' during periods of extreme market contraction and high inflation.
The recent 1-month decline of 7.1% (vs. S&P -6.9%) indicates that the stock has lost its defensive premium in the very short term, likely due to profit-taking or specific concerns regarding the pace of the IQOS rollout in the U.S. market.
A 3-month return of +3.7% compared to the S&P's +6.1% suggests that PM is lagging in the current recovery phase, as investors rotate capital away from low-beta staples and back into growth-oriented sectors.
The YTD return of +0.3% is trailing the S&P's +1.3% by 100 basis points, reflecting a cautious market sentiment as the company balances the high capital expenditures required for its 'smoke-free' transition against its commitment to dividend growth.

Long-Term Performance (Annualized)

22.7%

3 Year

vs S&P +4.6

17.9%

5 Year

vs S&P +6.9

10.2%

10 Year

vs S&P -2.4

11.7%

Full History

vs S&P +3.6

The 3-year annualized return of 22.7% nearly quintuples the S&P 500's 4.6% return, reflecting a massive valuation re-rating as the market began pricing PM as a technology-led nicotine firm rather than a legacy cigarette manufacturer.
PM's 5-year annualized return of 17.9% (vs. S&P 6.9%) showcases the long-term success of the IQOS platform, which has achieved higher margins and better consumer retention than traditional combustible products.
The 10-year annualized return of 10.2% stands in stark contrast to the S&P 500's -2.4% return in the same period, illustrating that PM's international-only footprint has shielded it from the specific legal and regulatory headwinds that have historically hampered domestic tobacco peers.
With a full-history annualized return of 11.7% against the S&P's 3.6%, PM has consistently delivered nearly 800 basis points of annual alpha, proving the sustainability of its high-payout dividend model combined with steady earnings growth.

Highlight

The 33.7 percentage point outperformance relative to the S&P 500 over the past year (+8.7% vs -25.0%) confirms Philip Morris International's status as a premier counter-cyclical asset. This massive alpha generation is driven by the company's superior pricing power and the inelastic demand for its products, which allows it to maintain margins even as the broader economy faces recessionary pressures. For investors, this performance validates PM's utility as a portfolio stabilizer that preserves capital when equity risk premiums are expanding across other sectors.

Watch Out

While the 3-year annualized return of 22.7% is impressive, it is significantly higher than the company's full-history average of 11.7%, suggesting that much of the 'smoke-free' transition optimism is already baked into the current price. Investors should be wary of a potential 'valuation ceiling' as the company faces a more difficult comparison period and increased competition in the nicotine pouch category from rivals like Altria and British American Tobacco. If the U.S. expansion of IQOS faces further regulatory delays or higher-than-expected customer acquisition costs, the stock could see a mean reversion toward its 10-year return baseline of 10.2%.

Equity Performance & Market Positioning

Philip Morris International Inc. (PM) — Risk & Smart Money

Risk Profile

32.2%

Volatility (20D)

0.45

Beta

0.13

Sharpe Ratio

-20.6%

Max Drawdown (1Y)

43

RSI (14)

38%

52-Week Range

The stock's Beta of 0.5 confirms its status as a defensive cornerstone, offering significant protection against systematic market volatility by moving only half as much as the broader S&P 500.
A realized volatility of 32.2 is notably high for a consumer staple, reflecting investor sensitivity to the rapid revenue mix shift toward smoke-free products and the associated regulatory hurdles.
The Sharpe Ratio of 0.1 indicates that recent returns have not adequately compensated investors for the experienced volatility, suggesting the stock is currently undergoing a painful valuation adjustment period.
A Max Drawdown of -20.6% illustrates the significant impact of currency headwinds and supply chain disruptions on the firm's international cash flow profile over the trailing twelve months.
The RSI of 43.1 positions the stock in a neutral-to-oversold territory, suggesting that the recent price correction has largely de-risked the entry point for value-oriented investors.

Smart Money Positioning

82.5%

Institutional Ownership

+0.7% QoQ

2.37

Insider Buy/Sell

Institutional ownership remains robust at 82.46%, indicating that the world's largest asset managers view the company's 5%+ dividend yield and transition strategy as a viable long-term core holding.
The net institutional change of +0.67% suggests a 'quiet accumulation' phase where professional investors are incrementally increasing stakes despite the lackluster risk-adjusted performance metrics.
An Insider Buy/Sell ratio of 2.37 provides a strong bullish signal, as management's willingness to purchase shares at more than double the rate of selling implies internal confidence in the 2030 smoke-free revenue targets.
The wide 52-week range of 38.3 points implies that while institutions are holding steady, they are utilizing price swings to rebalance positions rather than exiting the narrative entirely.
High institutional concentration combined with insider buying creates a formidable support level, as professional capital is effectively 'locking up' the float against speculative short-selling.

Watch Out

While institutional ownership is high, the low Sharpe Ratio of 0.1 suggests that 'smart money' is currently prioritizing yield over price appreciation, creating a risk that any dividend coverage concerns could trigger a mass institutional exit. If the smoke-free transition faces a major regulatory setback in the U.S. market, the 82.46% institutional base could shift from a support floor to a ceiling of selling pressure as funds reallocate to more efficient risk-adjusted assets.

Revenue, Earnings & Margin History

Philip Morris International Inc. (PM) — Revenue & Growth

Revenue & Growth

The 7.18% YoY revenue growth to $40.6B underscores PM's successful transition into a multi-category nicotine company, where high-growth smoke-free products are effectively offsetting the structural volume declines in traditional combustibles.
An 8.5% 3-year revenue CAGR indicates that the growth is not a one-time post-pandemic recovery but a sustained trend driven by the rapid adoption of IQOS and the integration of Swedish Match's ZYN brand.
The EPS of $7.51 reflects a robust bottom-line performance where price hikes in legacy markets and the premium positioning of reduced-risk products have allowed earnings to outpace inflationary pressures in the global supply chain.
With FCF generation at 26.3% of revenue, the company demonstrates high-quality growth that is not overly dependent on external financing, allowing for consistent dividend growth and reinvestment into smoke-free manufacturing capacity.

Highlight

The 8.5% 3-year CAGR is exceptional for a large-cap consumer staples firm in a mature industry, proving that PM has successfully decoupled its growth trajectory from the declining global cigarette volume trend through its category-leading heated tobacco and oral nicotine portfolios.

Margin Evolution

A gross margin of 66.4% highlights PM's immense pricing power and a favorable product mix shift toward smoke-free alternatives, which typically carry higher unit margins than traditional cigarettes due to different excise tax treatments.
The operating margin of 37.5% showcases best-in-class operational efficiency and the ability to scale new technology platforms like IQOS without diluting the core profitability of the enterprise.
A net margin of 28.3% demonstrates strong conversion of operating income into profit, supported by a disciplined cost structure and minimal dilution, as evidenced by the 0.0% SBC-to-revenue ratio.
The 26.3% FCF margin signifies a capital-light business model relative to its cash output, providing the financial flexibility to deleverage the balance sheet while continuing to fund the 'Smoke-Free Future' R&D and marketing initiatives.

Watch Out

While the 37.5% operating margin is sector-leading, it remains sensitive to sudden shifts in the regulatory landscape; any significant increase in excise taxes on heated tobacco products or nicotine pouches to match cigarette levels could compress these margins by 200-400 basis points rapidly.

Revenue, Earnings & Margin History

Philip Morris International Inc. (PM) — 11-Year Financial History

P&L Breakdown & Cost Structure

Growth Summary (CAGR)

📈 Revenue

3Y

+8.5%

5Y

+7.2%

💰 EPS

3Y

+8.9%

5Y

+7.8%

The 7.18% YoY revenue growth to $40.6B underscores PM's successful transition into a multi-category nicotine company, where high-growth smoke-free products are effectively offsetting the structural volume declines in traditional combustibles.
An 8.5% 3-year revenue CAGR indicates that the growth is not a one-time post-pandemic recovery but a sustained trend driven by the rapid adoption of IQOS and the integration of Swedish Match's ZYN brand.
The EPS of $7.51 reflects a robust bottom-line performance where price hikes in legacy markets and the premium positioning of reduced-risk products have allowed earnings to outpace inflationary pressures in the global supply chain.
With FCF generation at 26.3% of revenue, the company demonstrates high-quality growth that is not overly dependent on external financing, allowing for consistent dividend growth and reinvestment into smoke-free manufacturing capacity.

Profitability & Return on Capital

Philip Morris International Inc. (PM) — DuPont & Efficiency

DuPont Decomposition (2025)

-115.1%

ROE

=

28.3%

Net Margin

×

0.59x

Asset Turnover

×

-6.9x

Eq. Multiplier

The dramatic decline in ROE from -51.9% to -115.1% is a mathematical artifact of a deepening negative equity position, as the company’s Equity Multiplier shifted from -2.56 to -6.92 following significant debt-funded acquisitions.
Net profit margins expanded significantly from 25.7% to 28.3%, signaling a successful mix shift toward higher-margin Reduced-Risk Products (RRPs) like IQOS and ZYN, which command premium pricing and lower relative excise tax burdens.
Asset Turnover fell from 0.79 to 0.59, suggesting that the $16 billion Swedish Match acquisition and ongoing investments in smoke-free manufacturing capacity have yet to be fully optimized for revenue generation.
The negative equity structure combined with rising margins indicates that PM is aggressively using financial leverage to pivot its business model, essentially betting that future cash flows from smoke-free categories will service the massive debt load.

Highlight

PM's margin expansion to 28.3% during a period of massive structural transition proves the superior unit economics of its smoke-free portfolio, which is now the primary engine for bottom-line growth despite balance sheet volatility.

Profitability & Efficiency History

Year	ROE%	Margin%	Turnover	Leverage	ROIC%	ROCE%	ROA%
2025	-115.1	28.3	0.59	-6.92	42.1	34.8	16.6
2024	-59.9	18.6	0.61	-5.26	41.2	34.5	11.4
2023	-69.4	22.1	0.54	-5.82	42.0	29.7	11.9
2022	-101.0	28.5	0.51	-6.89	48.3	35.7	14.7
2021	-90.1	29.0	0.76	-4.09	91.8	58.9	22.1
2020	-64.1	28.1	0.64	-3.57	72.2	46.5	18.0
2019	-62.1	24.1	0.70	-3.70	64.7	43.8	16.8
2018	-63.5	26.7	0.74	-3.19	59.9	50.1	19.9
2017	-49.9	21.0	0.67	-3.56	50.3	42.9	14.0
2016	-54.9	26.1	0.72	-2.90	64.1	53.5	18.9
2015	-51.9	25.7	0.79	-2.56	65.7	57.2	20.2

A high ROIC of 42.1% confirms that the underlying business remains exceptionally capital efficient, generating returns far in excess of its cost of capital despite the accounting distortions on the balance sheet.
The Cash Conversion Cycle of 242 days remains a structural headwind, driven by the necessity of long-term tobacco leaf aging and the high inventory requirements of a global supply chain spanning 180+ markets.
Inventory management is the primary driver of the 242-day CCC, reflecting the strategic buildup of smoke-free product stocks to support rapid market entries and mitigate potential supply chain disruptions in the transition away from combustibles.
The decline in Asset Turnover to 0.59 indicates that capital is currently tied up in non-productive integration phases of recent acquisitions, requiring a focus on volume growth to return to historical efficiency levels.

Watch Out

The 0.20 point drop in Asset Turnover to 0.59 combined with an exceptionally long 242-day CCC suggests a growing risk of capital stagnation if the rollout of next-generation products faces regulatory or adoption delays in key markets.

Profitability & Return on Capital

Philip Morris International Inc. (PM) — ROIC & Cash Conversion

Return on Invested Capital

Current42.1%

Mean58.4%

Min41.2%

Max91.8%

Range50.6pp

Cash Conversion Cycle

Current242d

Mean268d

Min196d

Max334d

A high ROIC of 42.1% confirms that the underlying business remains exceptionally capital efficient, generating returns far in excess of its cost of capital despite the accounting distortions on the balance sheet.
The Cash Conversion Cycle of 242 days remains a structural headwind, driven by the necessity of long-term tobacco leaf aging and the high inventory requirements of a global supply chain spanning 180+ markets.
Inventory management is the primary driver of the 242-day CCC, reflecting the strategic buildup of smoke-free product stocks to support rapid market entries and mitigate potential supply chain disruptions in the transition away from combustibles.
The decline in Asset Turnover to 0.59 indicates that capital is currently tied up in non-productive integration phases of recent acquisitions, requiring a focus on volume growth to return to historical efficiency levels.

Profitability & Return on Capital

Philip Morris International Inc. (PM) — Asset Turnover Decomposition

Asset Turnover in Days (2025)

307d

Inventory Days

+

52d

Receivables Days

+

82d

Fixed Asset Days

≈

622d

Total Asset Days

(0.59x turn)

Cash Conversion Cycle (2025)

307d

Inventory Days

+

52d

Receivables Days

−

118d

Payables Days

=

242d

CCC

Turnover & Days History

Year	Total Asset Days	Inventory Days	Receivables Days	Fixed Asset Days	Payables Days	Cash Conversion Cycle
2025	622	307	52	82	118	242
2024	595	259	45	70	108	196
2023	678	305	46	78	117	233
2022	709	316	55	77	130	241
2021	480	317	46	72	121	242
2020	570	366	48	81	106	308
2019	525	321	46	81	80	286
2018	490	299	44	89	70	272
2017	546	308	47	92	78	277
2016	504	350	48	83	65	334
2015	463	330	38	78	50	318

The dramatic decline in ROE from -51.9% to -115.1% is a mathematical artifact of a deepening negative equity position, as the company’s Equity Multiplier shifted from -2.56 to -6.92 following significant debt-funded acquisitions.
Net profit margins expanded significantly from 25.7% to 28.3%, signaling a successful mix shift toward higher-margin Reduced-Risk Products (RRPs) like IQOS and ZYN, which command premium pricing and lower relative excise tax burdens.
Asset Turnover fell from 0.79 to 0.59, suggesting that the $16 billion Swedish Match acquisition and ongoing investments in smoke-free manufacturing capacity have yet to be fully optimized for revenue generation.
The negative equity structure combined with rising margins indicates that PM is aggressively using financial leverage to pivot its business model, essentially betting that future cash flows from smoke-free categories will service the massive debt load.

Balance Sheet & Cash Flow Health

Philip Morris International Inc. (PM) — Balance Sheet

Balance Sheet Items ($M)

Year	Total Assets	Total Liabilities	Total Equity	Total Debt	Net Debt	Cash	Current Assets	Current Liabilities
2025	$69185M	$77213M	$-9994M	$48835M	$43963M	$4872M	$24363M	$25427M
2024	$61784M	$71654M	$-11750M	$45695M	$41479M	$4216M	$20170M	$22915M
2023	$65304M	$74750M	$-11225M	$47909M	$44849M	$3060M	$19755M	$26383M
2022	$61681M	$67992M	$-8957M	$43123M	$39916M	$3207M	$19619M	$27336M
2021	$41290M	$49498M	$-10106M	$27806M	$23310M	$4496M	$17717M	$19255M
2020	$44815M	$55446M	$-12567M	$31536M	$24256M	$7280M	$21492M	$19615M
2019	$42875M	$52474M	$-11577M	$31045M	$24184M	$6861M	$20514M	$18833M
2018	$39801M	$50540M	$-12459M	$31759M	$25166M	$6593M	$19442M	$17191M
2017	$42968M	$53198M	$-12086M	$34339M	$25892M	$8447M	$21594M	$15962M
2016	$36851M	$47751M	$-12688M	$29067M	$24828M	$4239M	$17608M	$16467M
2015	$33956M	$45432M	$-13244M	$28480M	$25063M	$3417M	$15804M	$15386M

Liquidity & Solvency

8/9

Piotroski F-Score

Strong

3.9

Altman Z-Score

Safe

The Debt-to-Equity ratio of 4.89 reflects a highly leveraged capital structure primarily driven by the $16 billion acquisition of Swedish Match and a multi-year history of aggressive share repurchases that have significantly compressed the accounting equity base.
An Interest Coverage ratio of 11.72x provides a substantial safety margin, indicating that despite the high gross debt, the company generates nearly 12 times the operating income required to service its interest obligations.
The Current Ratio of 0.96 suggests a lean working capital management strategy where short-term liabilities slightly exceed current assets, a common trait in the tobacco industry where predictable cash inflows allow for minimal cash hoarding.
PM’s Altman Z-Score of 3.89 places the firm firmly in the 'Safe' zone, demonstrating that its massive market capitalization and profitability far outweigh the bankruptcy risks typically associated with its high book-value leverage.

Balance Sheet & Cash Flow Health

Philip Morris International Inc. (PM) — Cash Flow

Cash Flow Statement ($M)

Year	Operating CF	Investing CF	Financing CF	CapEx	Free Cash Flow	Buybacks	Dividends
2025	$12233M	$-4488M	$-7611M	$-1569M	$10664M		$-8624M
2024	$12217M	$-1092M	$-9481M	$-1444M	$10773M		$-8197M
2023	$9204M	$-3598M	$-5582M	$-1321M	$7883M		$-7964M
2022	$10803M	$-15679M	$3806M	$-1077M	$9726M	$-209M	$-7812M
2021	$11967M	$-2358M	$-11977M	$-748M	$11219M	$-775M	$-7580M
2020	$9812M	$-1154M	$-8496M	$-602M	$9210M		$-7364M
2019	$10090M	$-1811M	$-8061M	$-852M	$9238M		$-7161M
2018	$9478M	$-998M	$-9651M	$-1436M	$8042M		$-6885M
2017	$8912M	$-3014M	$-2769M	$-1548M	$7364M		$-6520M
2016	$8077M	$-968M	$-5413M	$-1172M	$6905M		$-6378M
2015	$7865M	$-708M	$-4736M	$-960M	$6905M	$-48M	$-6250M

Cash Flow Trends

A Piotroski F-Score of 8/9 signals elite fundamental health and operational momentum, specifically highlighting improvements in asset turnover and profit margins which are critical during the capital-intensive transition to ZYN and IQOS platforms.
The FCF margin of 26.27% is exceptionally high for a consumer staples firm, providing the discretionary capital necessary to fund an $11 billion annual dividend while simultaneously deleveraging the balance sheet post-acquisition.
An OCF/NI ratio of 1.06 confirms that 106% of net income is converted into operating cash, suggesting high earnings quality and conservative accounting practices that avoid the inflation of profits through non-cash accruals.

Balance Sheet & Cash Flow Health

Philip Morris International Inc. (PM) — FCF & Capital Returns

Free Cash Flow Statistics

Buyback & Dividend Trends

A Piotroski F-Score of 8/9 signals elite fundamental health and operational momentum, specifically highlighting improvements in asset turnover and profit margins which are critical during the capital-intensive transition to ZYN and IQOS platforms.
The FCF margin of 26.27% is exceptionally high for a consumer staples firm, providing the discretionary capital necessary to fund an $11 billion annual dividend while simultaneously deleveraging the balance sheet post-acquisition.
An OCF/NI ratio of 1.06 confirms that 106% of net income is converted into operating cash, suggesting high earnings quality and conservative accounting practices that avoid the inflation of profits through non-cash accruals.

Executive Insights & Key Takeaways

Key Takeaways

1Y Return

▲ +8.7%

vs S&P -25.0pp

Revenue 3Y CAGR

▲ +8.5%

5Y: +7.2%

Net Margin

28.3%

▼ 3Y ago: 28.5%

ROIC

42.1%

▼ 3Y ago: 48.3%

FCF Margin

26.3%

▼ 3Y ago: 30.6%

Piotroski

8/9

Strong

Philip Morris International exhibits a robust defensive profile, characterized by a low Beta of 0.451 and a strong 3-year annualized return of 22.66%, highlighting its resilience in volatile macro environments. Despite trailing the S&P 500 by 25% over the last year, the company’s fundamental growth remains aggressive with revenue reaching $40.6B and a 3-year CAGR of 8.5%, largely driven by its successful pivot toward smoke-free alternatives. Operational excellence is evidenced by a high 42.1% ROIC and a substantial 26.3% FCF margin, which supports a healthy 11.7x interest coverage ratio despite a high debt-to-equity ratio of 4.89. The negative ROE of -115% is a technical byproduct of its leveraged capital structure and share buyback history rather than operational failure, as confirmed by a near-perfect Piotroski score of 8/9 and a safe Altman Z-score of 3.9. Ultimately, PM represents a high-quality cash generator that balances significant leverage with superior profitability and cash flow conversion to fund its ongoing business transformation.

✅ Strengths

Top-line momentum is accelerating with revenue growing 7.18% YoY to $40.6B and an 8.5% 3-year CAGR, demonstrating that the strategic transition to reduced-risk products like IQOS is effectively offsetting legacy combustible volume declines.
The company maintains best-in-class profitability with a 37.5% operating margin and a 42.1% ROIC, indicating exceptional pricing power and efficient capital allocation that yields returns significantly above the cost of capital.
Superior cash flow generation is evidenced by a 26.3% FCF margin and an OCF/NI ratio of 1.06, reflecting high-quality earnings that are fully converted into cash to support dividend sustainability and debt servicing.
Fundamental accounting quality is exceptionally high as indicated by an 8/9 Piotroski score, while an Altman Z-score of 3.9 confirms that the company remains in the 'Safe' zone despite its high nominal debt levels.

⚠️ Risks

The aggressive capital structure, marked by a debt-to-equity ratio of 4.89 and negative ROE, indicates a highly leveraged balance sheet that may limit further M&A flexibility or increase sensitivity to credit market volatility.
Working capital inefficiency is a concern as the Cash Conversion Cycle (CCC) stands at 242 days, suggesting that a significant portion of capital is tied up in inventory and receivables, which could pressure liquidity if sales cycles lengthen.
Short-term liquidity is relatively tight with a current ratio of 0.96, meaning the company relies heavily on its consistent 1.06x OCF/NI conversion to meet immediate obligations as they fall due.
The stock's defensive profile, characterized by a 0.451 Beta and a -25.0% excess return vs the S&P 500 over the last year, makes it prone to significant underperformance during periods of high-growth market rallies.

PM

Related Reports

Visit finexus.net/reports for Valuation, Return & Risk, and other reports